Cargando…
Obesity, the Endocannabinoid System, and Bias Arising from Pharmaceutical Sponsorship
BACKGROUND: Previous research has shown that academic physicians conflicted by funding from the pharmaceutical industry have corrupted evidence based medicine and helped enlarge the market for drugs. Physicians made pharmaceutical-friendly statements, engaged in disease mongering, and signed biased...
Autor principal: | McPartland, John M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659447/ https://www.ncbi.nlm.nih.gov/pubmed/19333392 http://dx.doi.org/10.1371/journal.pone.0005092 |
Ejemplares similares
-
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
por: McPartland, John M., et al.
Publicado: (2014) -
Pharmaceutical Sponsorship Bias Influences Thrombolytic Literature in Acute Ischemic Stroke
por: Radecki, Ryan Patrick
Publicado: (2011) -
Sponsorship bias and quality of randomised controlled trials in veterinary medicine
por: Wareham, K. J., et al.
Publicado: (2017) -
Risky business? Pharmaceutical industry sponsorship of health consumer groups
por: Bero, Lisa A, et al.
Publicado: (2021) -
Industry sponsorship bias in cost effectiveness analysis: registry based analysis
por: Xie, Feng, et al.
Publicado: (2022)